Weersink RA - Search Results

1

[Safe prescribing in patients with liver cirrhosis; 5 pitfalls].

Weersink RA, Drenth JPH, Ter Borg F, Mulder MB, Taxis K, Borgsteede SD. Weersink RA, et al. Ned Tijdschr Geneeskd. 2020 Oct 29;164:D4952. Ned Tijdschr Geneeskd. 2020. PMID: 33201633 Dutch.

2

Consumers' questions about antipsychotic medication: revealing safety concerns and the silent voices of young men.

Weersink RA, Taxis K, McGuire TM, van Driel ML. Weersink RA, et al. Soc Psychiatry Psychiatr Epidemiol. 2015 May;50(5):725-33. doi: 10.1007/s00127-014-1005-y. Epub 2014 Dec 30. Soc Psychiatry Psychiatr Epidemiol. 2015. PMID: 25547083

3

Altered Pharmacokinetics of Statins Explain Increased Risk of Rhabdomyolysis in Advanced Cirrhosis.

Weersink RA, Drenth JP, Borgsteede SD. Weersink RA, et al. Gastroenterology. 2016 Nov;151(5):1036. doi: 10.1053/j.gastro.2016.06.055. Epub 2016 Oct 3. Gastroenterology. 2016. PMID: 27713044 No abstract available.

4

Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion.

Weersink RA, Bouma M, Burger DM, Drenth JP, Hunfeld NG, Kranenborg M, Monster-Simons MH, van Putten SA, Metselaar HJ, Taxis K, Borgsteede SD. Weersink RA, et al. BMJ Open. 2016 Oct 12;6(10):e012991. doi: 10.1136/bmjopen-2016-012991. BMJ Open. 2016. PMID: 27733414 Free PMC article. Review.

5

Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis.

Weersink RA, Bouma M, Burger DM, Drenth JPH, Harkes-Idzinga SF, Hunfeld NGM, Metselaar HJ, Monster-Simons MH, Taxis K, Borgsteede SD. Weersink RA, et al. Drug Saf. 2018 Jun;41(6):603-613. doi: 10.1007/s40264-017-0635-x. Drug Saf. 2018. PMID: 29330714 Free PMC article. Review.

6

Safe use of proton pump inhibitors in patients with cirrhosis.

Weersink RA, Bouma M, Burger DM, Drenth JPH, Harkes-Idzinga SF, Hunfeld NGM, Metselaar HJ, Monster-Simons MH, van Putten SAW, Taxis K, Borgsteede SD. Weersink RA, et al. Br J Clin Pharmacol. 2018 Aug;84(8):1806-1820. doi: 10.1111/bcp.13615. Epub 2018 Jun 7. Br J Clin Pharmacol. 2018. PMID: 29688583 Free PMC article.

7

Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study.

Weersink RA, Taxis K, Drenth JPH, Houben E, Metselaar HJ, Borgsteede SD. Weersink RA, et al. Drug Saf. 2019 Apr;42(4):539-546. doi: 10.1007/s40264-018-0744-1. Drug Saf. 2019. PMID: 30357649 Free PMC article.

8

Guidance for Safety and Dosing of Medicines in Patients With Cirrhosis Is Available.

Weersink RA, Drenth JPH, Hunfeld NGM, Borgsteede SD. Weersink RA, et al. Hepatol Commun. 2019 Jul 8;3(9):1281-1282. doi: 10.1002/hep4.1399. eCollection 2019 Sep. Hepatol Commun. 2019. PMID: 31497748 Free PMC article. No abstract available.

9

Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.

Weersink RA, Timmermans L, Monster-Simons MH, Mol PGM, Metselaar HJ, Borgsteede SD, Taxis K. Weersink RA, et al. Front Pharmacol. 2019 Sep 17;10:1031. doi: 10.3389/fphar.2019.01031. eCollection 2019. Front Pharmacol. 2019. PMID: 31607904 Free PMC article.

10

Medication safety in patients with hepatic impairment: A survey of community pharmacists' knowledge level and their practice in caring for these patients.

Weersink RA, Abadier M, de Boer A, Taxis K, Borgsteede SD. Weersink RA, et al. Br J Clin Pharmacol. 2020 Apr;86(4):763-770. doi: 10.1111/bcp.14177. Epub 2020 Feb 3. Br J Clin Pharmacol. 2020. PMID: 31756269 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters